Patents Represented by Attorney, Agent or Law Firm Amster, Rothstein & Ebenstein
  • Patent number: 8228425
    Abstract: The invention relates to an image sensor for electronic cameras, comprising a plurality of light-sensitive pixels for the generation of signals proportional to exposure and at least one read-out circuit coupled to the pixels and having a first section and a second section disposed downstream of the first section in a signal read-out direction, wherein the first section and the second section of the read-out circuit are each connected to at least one bond pad provided for the supply of an operating voltage and/or to at least one bond pad provided for the supply of a reference potential. At least some of the bond pads provided for the supply of the operating voltage and/or of the reference potential to the read-out circuit are arranged between the first section and the second sections of the read-out circuit.
    Type: Grant
    Filed: January 8, 2010
    Date of Patent: July 24, 2012
    Assignee: Arnold & Richter Cine Technik GmbH & Co. Betriebs KG
    Inventor: Michael Cieslinski
  • Patent number: 8225631
    Abstract: The invention relates to a hoop lock for two wheelers, wherein the hoop lock has a lock body and a substantially U-shaped hoop. The hoop is selectively releasable from the lock body or latchable to the lock body. The hoop has at least two wire sections which extend along the U-shape of the hoop alongside one another, and which are surrounded, at least regionally, by a sleeve.
    Type: Grant
    Filed: June 23, 2010
    Date of Patent: July 24, 2012
    Assignee: ABUS August Bremicker Sohne KG
    Inventor: Thomas Becker
  • Patent number: 8227466
    Abstract: Provided are methods of inhibiting prostaglandin transporter (PGT) activity in mammals. Also provided are methods of determining whether a test compound is an inhibitor of a prostaglandin transporter. Additionally provided are compounds that inhibit prostaglandin transporter activity, and pharmaceutical compositions of those compounds. Methods of inhibiting COX-2 in a mammal are also provided. Additionally, methods of treating pain or inflammation in a mammal are provided.
    Type: Grant
    Filed: May 15, 2007
    Date of Patent: July 24, 2012
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Victor L. Schuster, Yuling Chi, Young-Tae Chang, Jaeki Min
  • Patent number: 8217908
    Abstract: An electronic device including an interactive display having an interactive mode and a non-interactive mode. The interactive display comprises an image display device that displays a user-interactive imaged keypad in at least a portion of the image display device when the interactive display is in the interactive mode and that displays other image data in the at last a portion of the image display device when the interactive display is in the non-interactive mode, and a substantially transparent physical keypad that provides tactile feedback to a user indicating location of keys within the imaged keypad.
    Type: Grant
    Filed: June 19, 2008
    Date of Patent: July 10, 2012
    Assignee: Tactile Displays, LLC
    Inventor: R. O'Neal Gray
  • Patent number: 8209252
    Abstract: A method of protecting at least a portion of an initial investment value of an investment made by one or more investors, comprising the steps of: (a) determining using an option-based instrument calculator: (i) a first value of a first set of put option-based instruments at initial investment in the first set of put option-based instruments, the first set of put option-based instruments having a first underlying reference; (ii) a second value of a first set of call option-based instruments at initial investment in the first set of call option-based instruments, the first set of call option-based instruments having a second underlying reference, the first underlying reference being the same as or substantially correlated to the second underlying reference; and (iii) a third value of a second set of option-based instruments at initial investment in the second set of option-based instruments, the second set of option-based instruments having a third underlying reference; so that the sum of the first value, the s
    Type: Grant
    Filed: November 25, 2008
    Date of Patent: June 26, 2012
    Assignee: Barclays Bank PLC
    Inventors: Samson Koo, Stephen Douglas
  • Patent number: 8205568
    Abstract: A workboat comprises a floatable body having a bow and a stern, a mast having at least two rails mounted at the bow, a carriage that is movable longitudinally along the rails of the mast, and at least two forks extending outwardly from the carriage for lifting items in the water.
    Type: Grant
    Filed: October 22, 2009
    Date of Patent: June 26, 2012
    Inventor: Jeffrey R. Braun
  • Patent number: 8205237
    Abstract: A media work may be associated with an action by (a) extracting features from the media work, (b) determining an identification of the media work, based on the features extracted, using a sub-linear time search, such as an approximate nearest neighbor search for example, and (c) determining an action based on the identification of the media work determined. The media work may be an audio work. The features extracted from the work may include (A) a frequency decomposition of a signal of the audio work, (B) information samples of the audio work, (C) average intensities of sampled windows of the audio work, and/or (D) information from frequencies of the audio work.
    Type: Grant
    Filed: October 23, 2007
    Date of Patent: June 19, 2012
    Inventor: Ingemar J. Cox
  • Patent number: 8197932
    Abstract: A large, high density foam glass tile which can be used as a facade on both exterior and interior building walls. The foam glass tile can also be used with other materials to form a panel or a composite. The present invention may be used on the critical surfaces of buildings at high risk for terrorist attacks, in combination with cement, steel or other high strength building materials. The present invention may also be used in surfaces of typical buildings. The present invention has the advantage of absorbing a substantial portion of a shock wave caused by an explosion. The present invention also has the advantage of being more resistant to earthquakes.
    Type: Grant
    Filed: June 6, 2011
    Date of Patent: June 12, 2012
    Inventors: Pedro M. Buarque de Macedo, Hamid Hojaji
  • Patent number: 8193247
    Abstract: Provided are various compounds of Formula (I): Also provided are pharmaceutical compositions comprising the above compounds. Additionally, methods of inhibiting macrophage migration inhibitory factor (MIF) activity in a mammal are provided, as are methods of treating or preventing inflammation in a mammal. Further provided are methods of treating a mammal having sepsis, septicemia, and/or endotoxic shock. Also provided are methods of treating a mammal having an autoimmune disease, and methods of treating a mammal having a tumor.
    Type: Grant
    Filed: March 23, 2007
    Date of Patent: June 5, 2012
    Assignee: The Feinstein Institute for Medical Research
    Inventor: Yousef Al-Abed
  • Patent number: 8187589
    Abstract: The present invention relates to a process for stabilizing aqueous preparations of minerals by adding reuterin to the aqueous preparations, to the use of reuterin for the stabilization of such aqueous mineral preparations, and the aqueous mineral preparations containing reuterin.
    Type: Grant
    Filed: August 19, 2009
    Date of Patent: May 29, 2012
    Assignee: Omya Development AG
    Inventors: Patrick Schwarzentruber, Nicola Di Maiuta
  • Patent number: 8187611
    Abstract: The present invention provides a purified peptide comprising at least one of the sequences LKQKSSNSRKKRSTS (SEQ ID NO:1), or VKNKRTFLSPWISNI (SEQ ID NO:2) as well as a vaccine, a method to protect or treat an animal from anthrax toxin, a method of making a vaccine and the use of the peptide. The present invention also provides a monoclonal antibody that specifically binds to a peptide sequence comprising at least one of the following peptide sequences: LKQKSSNSRKKRSTS (SEQ ID NO:1), or VKNKRTFLSPWISNI (SEQ ID NO:2) as well as a method to protect or treat an animal from anthrax toxin, a method of making a vaccine, a pharmaceutical composition, a method of making a pharmaceutical composition, and the use of the monoclonal antibody.
    Type: Grant
    Filed: October 5, 2010
    Date of Patent: May 29, 2012
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Nareen Abboud, Arturo Casadevall
  • Patent number: 8182458
    Abstract: An absorbent article including a front waist region having an inner surface, and outer surface, a first lateral end portion and a second lateral end portion, a back waist region having an inner surface, and outer surface, a first lateral end portion and a second lateral end portion, a crotch portion longitudinally connecting the front and back waist regions, and at least one fastener disposed at each of the first and second lateral end portions of the back waist region or the front waist region. The at least one fastener includes a backing layer having a first end portion permanently attached to the back waist region or the front waist region and a second end portion opposite the first end portion, an adhesive layer disposed over at least a portion of the backing layer, a fastening material layer disposed over the adhesive layer at the second end portion of the backing layer, and an outer surface that is free of adhesive to form an adhesive-free region, wherein a fold is formed in the adhesive-free region.
    Type: Grant
    Filed: October 4, 2006
    Date of Patent: May 22, 2012
    Assignee: First Quality Products, Inc.
    Inventor: Hamzeh Karami
  • Patent number: 8183019
    Abstract: A process is disclosed for preparing (3R,4R)-3-hydroxy-4-hydroxymethylpyrrolidine, the compound of formula (I), or (3S,4S)-3-hydroxy-4-hydroxymethylpyrrolidine, the compound of formula (Ia) involving, as a key step, the enzyme-catalysed enantioselective hydrolysis of a racemic 3,4-trans-disubstituted pyrrolidinone compound of formula (II).
    Type: Grant
    Filed: June 3, 2005
    Date of Patent: May 22, 2012
    Assignee: Industrial Research Limited
    Inventors: Dirk Henning Lenz, Jennifer Mary Mason, Keith Clinch, Gary Brian Evans, Peter Charles Tyler
  • Patent number: 8173604
    Abstract: Methods of killing a cancer cell are provided. Also provided are methods of treating a subject having a cancer. Additionally, compounds are provided that comprise a peptide from about 18 to about 100 amino acids or peptidomimetics comprising the sequence of SEQ ID NO:1. Additionally provided are methods of screening an agent for the ability to kill a cancer cell.
    Type: Grant
    Filed: May 23, 2007
    Date of Patent: May 8, 2012
    Assignee: Albert Einstein College of Medicine of Yeshiva University
    Inventors: Liang Zhu, Peng Ji
  • Patent number: 8176042
    Abstract: A computer-implemented method of linking a predefined set of electronic data sources comprises electronically identifying a query data item and one or more query dimensions based on a query statement, electronically determining first data sources in which at least one of one or more source fields is equivalent to the query data item, determining whether any one of the first data sources has the ability to provide the data related to the one or more query dimensions, and identifying one or more second data sources within the database corresponding to one or more of the first data sources if it is determined that the first data sources do not have the ability to provide data related to the one or more query dimensions.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: May 8, 2012
    Assignee: Elumindata, Inc.
    Inventors: Russell Baris, Ray Pan, Arthur Kruk
  • Patent number: 8173662
    Abstract: The present invention relates to compounds of the general formula (I) which are inhibitors of purine muclioside phosphorylases (PNP), purine phosphoribosyltransferases (PPRT), 5?-methylthioadenosine phosphorylases (MTAP), 5?-methylthioadenosine mucliosidases (MTAN) and/or nucleoside hydrolases (NH). The invention also relates to the use of these compounds in the treatment of diseases and infections including cancer, bacterial infections, protozoal infections, and T-cell mediated disease and to pharmaceutical compositions containing the compounds.
    Type: Grant
    Filed: June 3, 2009
    Date of Patent: May 8, 2012
    Assignees: Industrial Research Limited, Albert Einstein College of Medicine of Yeshiva University
    Inventors: Gary Brian Evans, Richard Hubert Furneaux, Dirk Henning Lenz, Vern L. Schramm, Peter Charles Tyler, Olga Vladimirovna Zubkova
  • Patent number: D658083
    Type: Grant
    Filed: September 24, 2009
    Date of Patent: April 24, 2012
    Assignee: Christian Dior Couture, S.A.
    Inventors: Antonin Ghirardi, Cécile Rembauville
  • Patent number: D658852
    Type: Grant
    Filed: September 19, 2011
    Date of Patent: May 8, 2012
    Assignee: Occunomix International LLC
    Inventor: Jennifer McCoy
  • Patent number: D659555
    Type: Grant
    Filed: January 19, 2012
    Date of Patent: May 15, 2012
    Assignee: Christian Dior Couture, S.A.
    Inventor: Mathieu Jamin
  • Patent number: D663437
    Type: Grant
    Filed: April 20, 2011
    Date of Patent: July 10, 2012
    Assignee: Dylan's Candybar, LLC
    Inventors: Dylan Lauren, John Bricker